bioCatalyst Roundtable Series

AI can analyse trends and surface patterns in seconds — but the priorities, trade-offs, and strategic tensions that shape real decisions rarely show up in a spreadsheet.

That’s why we created the bioCatalyst Roundtable Series: a confidential forum for senior biopharma leaders to exchange perspectives on the challenges they’re actively navigating.

These are not panel discussions or webinars.

Each session brings together a small group of experienced executives — often spanning both the US and Europe — to explore a focused topic in an informal, off-the-record setting. The goal isn’t to reach consensus, but to surface nuance, share lived experience, and compare how others are thinking through similar complexities.

What emerges from these conversations is often richer than what any framework or trend report can offer. The white papers that follow distil these insights — anonymized where needed, detailed where it helps — to reflect the real-world thinking of senior decision-makers.

Whether it’s building partnerships, launching in rare disease, or aligning strategy across functions, understanding how others are approaching the same inflection points can be invaluable. And the most honest, useful insights often come from dialogue — not data.

If you're interested in joining a future session or suggesting a topic, we’d love to hear from you.